|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/19/23 Accustem Sciences Inc. S-1/A 57:7M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: S-1/A Pre-Effective Amendment to Registration Statement HTML 2.19M
(General Form)
2: EX-5.1 Opinion of Counsel re: Legality HTML 29K
3: EX-23.1 Consent of Expert or Counsel HTML 16K
4: EX-FILING FEES Filing Fees HTML 24K
10: R1 Cover HTML 57K
11: R2 Consolidated Balance Sheets HTML 105K
12: R3 Consolidated Balance Sheets (Parenthetical) HTML 35K
13: R4 Consolidated Statements of Operations and HTML 66K
Comprehensive Income (Loss)
14: R5 Consolidated Statements of Shareholders' Equity HTML 80K
15: R6 Consolidated Statements of Cash Flows HTML 95K
16: R7 Nature of Business HTML 50K
17: R8 Summary of Significant Accounting Policies HTML 75K
18: R9 Acquisition of Stemprinter Sciences Limited and HTML 33K
Equity Raise
19: R10 Note Payable HTML 25K
20: R11 Equipment HTML 26K
21: R12 License HTML 38K
22: R13 Loss Per Share HTML 67K
23: R14 Share-Based Compensation HTML 187K
24: R15 Related Party Transactions HTML 32K
25: R16 Income Taxes HTML 102K
26: R17 Commitments and Contingencies HTML 23K
27: R18 Subsequent Events HTML 26K
28: R19 Summary of Significant Accounting Policies HTML 117K
(Policies)
29: R20 Equipment (Tables) HTML 23K
30: R21 Loss Per Share (Tables) HTML 64K
31: R22 Share-Based Compensation (Tables) HTML 161K
32: R23 Income Taxes (Tables) HTML 90K
33: R24 Nature of Business (Details Narrative) HTML 69K
34: R25 Summary of Significant Accounting Policies HTML 23K
(Details Narrative)
35: R26 Acquisition of Stemprinter Sciences Limited and HTML 37K
Equity Raise (Details Narrative)
36: R27 Note Payable (Details Narrative) HTML 32K
37: R28 Schedule of Property and Equipment (Details) HTML 25K
38: R29 Equipment (Details Narrative) HTML 19K
39: R30 License (Details Narrative) HTML 25K
40: R31 Schedule of Loss Per Share (Details) HTML 44K
41: R32 Schedule of Computation of Diluted Net Loss Per HTML 23K
Share (Details)
42: R33 Schedule of Stock Option Activity (Details) HTML 73K
43: R34 Schedule of Stock Based Compensation Expenses HTML 24K
(Details)
44: R35 Schedule of Stock Valuation Assumptions (Details) HTML 42K
45: R36 Schedule of Warrants Outstanding (Details) HTML 51K
46: R37 Share-Based Compensation (Details Narrative) HTML 80K
47: R38 Related Party Transactions (Details Narrative) HTML 47K
48: R39 Schedule of Domestic and Foreign Components of HTML 28K
Loss Before Income Taxes (Details)
49: R40 Schedule of Reconciliation Provision for Income HTML 30K
Taxes (Details)
50: R41 Schedule of Deferred Income Tax Assets (Details) HTML 25K
51: R42 Income Taxes (Details Narrative) HTML 27K
52: R43 Subsequent Events (Details Narrative) HTML 40K
55: XML IDEA XML File -- Filing Summary XML 99K
53: XML XBRL Instance -- forms-1a_htm XML 1.34M
54: EXCEL IDEA Workbook of Financial Reports XLSX 104K
6: EX-101.CAL Inline XBRL Taxonomy Extension Calculation XML 108K
Linkbase Document -- acut-20220930_cal
7: EX-101.DEF Inline XBRL Taxonomy Extension Definition Linkbase XML 404K
Document -- acut-20220930_def
8: EX-101.LAB Inline XBRL Taxonomy Extension Label Linkbase XML 718K
Document -- acut-20220930_lab
9: EX-101.PRE Inline XBRL Taxonomy Extension Presentation XML 561K
Linkbase Document -- acut-20220930_pre
5: EX-101.SCH Inline XBRL Taxonomy Extension Schema Document -- XSD 89K
acut-20220930
56: JSON XBRL Instance as JSON Data -- MetaLinks 295± 442K
57: ZIP XBRL Zipped Folder -- 0001493152-23-001932-xbrl Zip 644K
Exhibit 107
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
ACCUSTEM SCIENCES, INC.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Title of each Class of Securities to be Registered | Amount Registered (1) | Proposed Maximum Offering Price Per Share(2)(3)(4) | Maximum Aggregate Offering Price(1)(2) | Amount of Registration Fee(3) | ||||||||||||
| Common Stock, par value $0.001 per share(4) | — | — | $ | 12,650,000 | $ | 1,394 | ||||||||||
| Representative’s Warrants(5) | ||||||||||||||||
| Shares of Common Stock issuable upon exercise of the Representative’s Warrants(6) | — | — | $ | 474,375 | $ | 52 | ||||||||||
| Total | — | $ | 13,124,375 | $ | 1,446 | |||||||||||
| Registration Fee Previously Paid | $ | 1,444 | ||||||||||||||
| Registration Fee Paid Herewith | $ | 302 | ||||||||||||||
| (1) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”). |
| (2) | Pursuant to Rule 416(a) under the Securities Act, there is also being registered hereby an indeterminate number of shares that may be issued and resold resulting from stock splits, stock dividends or similar transactions. |
| (3) | Calculated under Section 6(b) of the Securities Act as .00011020 times the proposed maximum aggregate offering price. |
| (4) | Includes the aggregate offering price of additional shares that the underwriters have the right to purchase from the Registrant, if any. |
| (5) | No additional registration fee is payable pursuant to Rule 457(g) or Rule 457(i) under the Securities Act. |
| (6) | Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The representative’s warrants are exercisable for up to the number of shares of common stock equal to 3% of the aggregate number of shares sold in this offering at a per share exercise price equal to 125% of the public offering price of the shares. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the representative’s warrants is $474,375, which is equal to 125% of $379,500, (3% of the proposed maximum aggregate offering price of $12,650,000. |
C:
| - C: 1- |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/17/22 Accustem Sciences Inc. S-1 66:33M M2 Compliance LLC/FA 9/14/22 Accustem Sciences Inc. DEF 14A 9/14/22 1:354K M2 Compliance LLC/FA 12/03/21 Accustem Sciences Inc. 8-K:1,2,3,512/01/21 7:813K M2 Compliance LLC/FA 3/12/21 Accustem Sciences Inc. 20FR12G 8:2.2M Donnelley … Solutions/FA |